Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
McKinsey
Medtronic
Merck
McKesson

Last Updated: December 2, 2022

Imipramine pamoate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for imipramine pamoate and what is the scope of patent protection?

Imipramine pamoate is the generic ingredient in two branded drugs marketed by Hikma, Lupin Ltd, Rising, and Specgx Llc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for imipramine pamoate. Two suppliers are listed for this compound.

Drug Prices for imipramine pamoate

See drug prices for imipramine pamoate

Recent Clinical Trials for imipramine pamoate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shalvata Mental Health CenterN/A
Roxane LaboratoriesN/A

See all imipramine pamoate clinical trials

Pharmacology for imipramine pamoate

US Patents and Regulatory Information for imipramine pamoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising IMIPRAMINE PAMOATE imipramine pamoate CAPSULE;ORAL 202338-004 Jun 28, 2013 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Specgx Llc TOFRANIL-PM imipramine pamoate CAPSULE;ORAL 017090-003 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Specgx Llc TOFRANIL-PM imipramine pamoate CAPSULE;ORAL 017090-004 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hikma IMIPRAMINE PAMOATE imipramine pamoate CAPSULE;ORAL 091099-004 Apr 16, 2010 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Moodys
Baxter
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.